Clinical Trial Update: Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases [Phase 2]

View source ↗

Summary

Phase 2 study evaluating pembrolizumab in combination with standard cytotoxic chemotherapy as first-line treatment for treatment-naive non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Keytruda (Pembrolizumab) (pembrolizumab)

Snippet

Sponsor: Samsung Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-05-09